findmyKOL
Clinical trialNCT00379470CompletedPhase 3Interventional

Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)

SponsorNovoCure Ltd.Enrollment236Recurrent Glioblastoma Multiforme
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Phillip Gutin, MD

    Memorial Sloan Kettering Cancer Center

    Principal Investigator
  • Roger Stupp, MD

    University of Lausanne Hospital - Multidisciplinary Oncology Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • University Hospital Graz

    Graz, Austria

Czechia
  • Fn Brno - Masaryk University

    Brno, Czechia

  • Na Homolce Hospital

    Prague, Czechia

France
  • Hospital of Neurology Lyon - University Claude Bernard Lyon 1

    Lyon, France

  • Group Hospitals Pitie-Salpetriere

    Paris, France

Germany
  • University Hospital Augsburg

    Augsburg, Germany

  • University Medical Center Hamburg-Eppendorf

    Hamburg, Germany

  • University Hospital of Schleswig-Holstein

    Kiel, Germany

Israel
  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel

Switzerland
  • Centre Hospitalier Universitaire Vaudois

    Lausanne, Switzerland

United States
  • Northwestern University

    Chicago, Illinois, United States

  • University of Illinois in Chicago

    Chicago, Illinois, United States

  • Evanston Northwestern Healthcare

    Evanston, Illinois, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • Boston University Medical Center

    Boston, Massachusetts, United States

  • Lahey Clinic Medical Center

    Burlington, Massachusetts, United States

  • Nj Neuroscience Institute - Jfk Medical Center

    Edison, New Jersey, United States

  • Columbia University Medical Center

    New York, New York, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

  • Weill Cornell Medical College

    New York, New York, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • University Hospitals of Cleveland

    Cleveland, Ohio, United States

  • University of Pittsburgh Medical Center (upmc)

    Pittsburgh, Pennsylvania, United States

  • University of Virginia

    Charlottesville, Virginia, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2006
Primary completion
30 Nov 2009
Completion
31 Jan 2011
Last update posted
1 May 2012
Registered enrollment
236
Registry id
NCT00379470

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.